Targeting EZH2 in advanced prostate cancer
Research Grant
Administered By
Pathology
Awarded By
National Institutes of Health
Start Date
April 1, 2026
End Date
March 31, 2031
Administered By
Pathology
Awarded By
National Institutes of Health
Start Date
April 1, 2026
End Date
March 31, 2031